Video

Nadia Waheed, MD, MPH: OCT Angiography Predicts DR Progression

Author(s):

A new study from AAO 2020 is the first to show a significant association between peripapillary vessel density loss and progression of diabetic retinopathy.

A study presented at the American Academy of Ophthalmology (AAO) 2020 Virtual Conference showed that optical coherence tomography (OCT) angiography metrics at baseline have the potential to predict risk of diabetic retinopathy progression at year 1.

The investigators performed color fundus photography as well as 3x3 and 6x6 macular scans, which were analyzed by a reading center.

They defined disease progression as either a ≥2-step increase in DRSS score or the development of diabetic macular edema (DME).

Thus, they enrolled a total of 167 individuals, 77 of which were affiliated with sites that had OCT angiography machines available. Within that subgroup, 73 patients had long-term progression data over the course of 1 year.

Enrolled patients were ≥18 years, had moderate-to severe diabetic retinopathy (ETDRS 43-53), had no center involved (DME), and had best correct visual acuity (BCVA) ≥ 70.

According to their multivariate logistic regression analysis, diabetic retinopathy progression was associated with enlarged foveal avascular zone (FAZ) area (4.75; OR, 115.6; P = .019), the presence of intraretinal microvascular abnormalities (IrMA) (3.00; OR, 20.09; P = .008), and decreased temporal peripapillary vessel density (superior and inferior).

In an interview with HCPLive®, study investigator Nadia Waheed, MD, MPH, Retina Specialist and Associate Professor, Tufts University School of Medicine, suggested that these associations were not particulary surprising.

“Intuitively, we’ve always known that,” she said. “We do fluorescein angiography to give us an idea of how the patient is doing and how the patient’s vasculature is doing. And this is kind of just a direct correlate to that.”

Related Videos
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
© 2024 MJH Life Sciences

All rights reserved.